These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets. Siddiqui O J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517 [TBL] [Abstract][Full Text] [Related]
5. An overview of practical approaches for handling missing data in clinical trials. DeSouza CM; Legedza AT; Sankoh AJ J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464 [TBL] [Abstract][Full Text] [Related]
6. Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Wood AM; White IR; Hillsdon M; Carpenter J Int J Epidemiol; 2005 Feb; 34(1):89-99. PubMed ID: 15333619 [TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. Hall SM; Delucchi KL; Velicer WF; Kahler CW; Ranger-Moore J; Hedeker D; Tsoh JY; Niaura R Nicotine Tob Res; 2001 Aug; 3(3):193-202. PubMed ID: 11506764 [TBL] [Abstract][Full Text] [Related]
8. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation. Cook RJ; Zeng L; Yi GY Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307 [TBL] [Abstract][Full Text] [Related]
9. Accounting for dropout bias using mixed-effects models. Mallinckrodt CH; Clark WS; David SR J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446 [TBL] [Abstract][Full Text] [Related]
10. Comparisons of methods for analysis of repeated binary responses with missing data. Frank Liu G; Zhan X J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts. Siddiqui O; Ali MW J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033 [TBL] [Abstract][Full Text] [Related]
12. Missing data in randomized controlled trials of rheumatoid arthritis with radiographic outcomes: a simulation study. Baron G; Ravaud P; Samson A; Giraudeau B Arthritis Rheum; 2008 Jan; 59(1):25-31. PubMed ID: 18163406 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal studies in rheumatology: some guidance for analysis. Lesaffre E Bull NYU Hosp Jt Dis; 2012; 70(2):65-72. PubMed ID: 22891996 [TBL] [Abstract][Full Text] [Related]
14. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Leon AC; Mallinckrodt CH; Chuang-Stein C; Archibald DG; Archer GE; Chartier K Biol Psychiatry; 2006 Jun; 59(11):1001-5. PubMed ID: 16503329 [TBL] [Abstract][Full Text] [Related]
15. Handling missing data issues in clinical trials for rheumatic diseases. Wong WK; Boscardin WJ; Postlethwaite AE; Furst DE Contemp Clin Trials; 2011 Jan; 32(1):1-9. PubMed ID: 20840873 [TBL] [Abstract][Full Text] [Related]
16. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. Siddiqui O; Hung HM; O'Neill R J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876 [TBL] [Abstract][Full Text] [Related]